Oscar Health (OSCR) Stock Tumbles 10% After Delivering Record Quarterly Earnings

Key Takeaways

Table of Contents

Shares of Oscar Health fall 10.66% following record-breaking quarterly results.
Quarterly revenue climbs to $4.88 billion driven by expanding membership and premium increases.
Company swings to $361.8 million profit versus $228.4 million loss in prior year.
Full-year 2026 operating income forecast upgraded to potential $700 million ceiling.
Total membership reaches 2.96 million amid individual market expansion efforts.

Shares of Oscar Health (OSCR) declined 10.66% to $26.90 during late-morning sessions even after delivering impressive second-quarter financial results and upgrading annual projections. The health insurance provider demonstrated revenue expansion, improved medical cost ratios, and a dramatic turnaround to profitability. Nevertheless, investors responded negatively, triggering a significant selloff.

Oscar Health, Inc., OSCR

Insurer Achieves Historic Quarterly Profitability

Oscar Health reported second-quarter revenue of $4.88 billion, marking a substantial increase from $2.86 billion recorded during the same quarter last year. The growth stemmed primarily from increased member enrollment and higher premium rates, though risk adjustment transfers partially offset these gains. The insurer continues broadening its presence within the individual health insurance sector.

The company achieved operating income of $388.6 million, a remarkable turnaround from the $230.5 million operating deficit posted in the comparable prior-year period. Net earnings totaled $361.8 million versus the $228.4 million loss reported twelve months earlier. Earnings per diluted share came in at $1.10, contrasting sharply with the $0.89 per share loss from the previous year.

Adjusted EBITDA surged to $415.3 million compared to a negative $199.4 million in the year-ago quarter. The medical loss ratio demonstrated significant improvement, declining to 79.2% from 91.1% in the prior period. Strategic pricing decisions combined with $164 million in favorable reserve adjustments contributed to this enhanced performance.

Company Significantly Boosts Full-Year Financial Projections

Oscar Health maintained its 2026 revenue projection in the $18.7 billion to $19.0 billion range. The company substantially increased its operating income outlook to a range of $500 million to $700 million. This represents a major upgrade from the prior guidance of $250 million to $450 million.

Management revised the anticipated medical loss ratio downward to 81.5% to 82.5%. The previous forecast called for a range of 82.4% to 83.4% for the full year. This adjustment reflects enhanced underwriting discipline and more effective management of healthcare costs.

The insurer also lowered its projected selling, general, and administrative expense ratio to 15.6% to 16.1%. Prior expectations placed this metric between 15.8% and 16.3%. Improved operational efficiency and rigorous expense controls enabled this favorable revision.

Member Base Expansion Bolsters Competitive Standing

Oscar Health finished the quarter with 2.96 million members enrolled in individual and related insurance products. This represents substantial growth from 2.03 million members during the corresponding period in 2025. The increase demonstrates sustained market appetite for the company’s individual health coverage offerings.

Management discontinued its small group business and ended its previous partnership with Cigna. The company now concentrates primarily on individual coverage products, including individual coverage health reimbursement arrangements. This strategic shift provides enhanced exposure to individuals transitioning between different employment situations and work arrangements.

Oscar Health has leveraged disciplined pricing strategies and technology platform investments to drive both growth and profitability improvements. The quarterly performance showcased enhanced underwriting results, reduced operating costs, and expanded member enrollment. Despite these achievements, Oscar Health stock experienced a sharp decline as market participants reacted unfavorably to the announcement.

✨ Limited Time Offer